Therefore, the interplay between CD47 and CALR underscores their integral roles in modulating immune responses and presents promising avenues for therapeutic strategies, which should be oriented to selectively upregulate CALR and quench CD47 signaling on cancer cells. The gene discussed is CD47; the disease is cancer.